AbbVie Expands Immunology Portfolio in the European Union with the European Commission Approval of SKYRIZI (risankizumab) for the Treatment of Adults with Active...

Mount Carmel Register

Nov 17, 2021

AbbVie Expands Immunology Portfolio in the European Union with the European Commission Approval of SKYRIZI (risankizumab) for the Treatment of Adults with Active Psoriatic Arthriti…